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Background: Human milk bioactives may play a role in infant health and development.
Although the variability in their concentrations in milk is well-established, the impact of
differential milk profiles on infant growth outcomes remains unclear. Thus, the aim of the
present study was to investigate whether different concentrations of metabolic hormones
are associated with different weight and BMI in infants beyond the first year of life.
Methods: Milk samples at 2.6 (±0.4) months after birth and anthropometric measures
at 13 months, 2, 3, and 5 years were collected as part of the Finnish STEPS cohort study
from 501 mothers and the respective 507 infants. Leptin, adiponectin, insulin-like growth
factor (IGF)-1 and cyclic glycine-proline (cGP) in milk were analyzed. Multiple regression
models and a repeated measures mixed model were used to examine associations
between milk hormone concentrations and weight and BMI z-scores across time, at
each time-point, and weight gain from birth to each follow-up visit. All models were
corrected for birth weight, infant sex, duration of exclusive and total breastfeeding, time
of introduction of solid foods and maternal pre-pregnancy BMI.
Results: Higher milk IGF-1 was associated with higher weight at 13 months (p= 0.004)
but lower weight at 3 (p = 0.011) and 5 years of age (p = 0.049). Higher cGP was
associated with lower weight across the 5 years (p = 0.019) but with higher BMI at 5
years (p = 0.021). Leptin and adiponectin did not display associations with infant growth
at this time. Sex interactions were also absent.
Conclusions: Our results suggest that the interplay between human milk-borne IGF-1
and cGP is similar to that reported in other mammals and may have an important role
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in defining infant growth trajectories beyond the first year of life. Further research should
explore the determinants and origins of these milk-borne compounds and evaluate their
effect on infant growth and metabolism.
Keywords: BMI, cGP, human breastmilk bioactives, IGF-1, growth factors, adiponectin, leptin, infant growth
INTRODUCTION
Breastfeeding is the gold standard for infant nutrition. However,
the importance of human milk (HM) for infants goes beyond
meeting their nutritional needs. It is well-established that
HM consumption is associated with lower risk of longer-term
morbidities, including obesity (1, 2) and metabolic syndrome (3),
which constitute major public health issues worldwide (4). As the
concept of nutritional programming during “the first 1,000 days
of life” is gaining recognition (5, 6), HM-borne hormones that
regulate metabolic function are seen as potential programming
factors (7–9). Evidence from animal models suggests that
HM leptin (10) influences infant eating behavior and body
composition (11) and may underpin the protective effects of
breastfeeding against obesity (12). The presence of adipokine
receptors in the epithelial cells of the infant gastrointestinal tract
(13, 14) together with the knowledge that human neonates are
capable of absorbing intact macromolecules during the early
neonatal period (15, 16) reinforces the hypothesis that these HM-
borne molecules have a functional role in infant metabolism.
Additionally, other hormones, including insulin-like growth
factor (IGF)-1, together with its binding proteins and regulatory
metabolites, including cyclic Glycine-Proline (cGP), also have
a potential role in programming infant growth trajectories
due to their well-established roles in linear growth, and body
composition (17).
As variations in circulating adipokines (18), IGF-1 and cGP
(19, 20) have been linked to various health and disease outcomes
and significant differences in HM hormone concentrations have
been described across mother-infant dyads (21–23), research
has focused on associations between hormone concentrations
in HM and infant growth outcomes (24–36). However, while
some studies suggest that individual hormonal signatures in
HM are associated with different infant growth trajectories, the
findings of research in this area remains conflicting (37). Yet, the
pattern of early postnatal growth beyond the first year of life is
a known predictor of later metabolic health (38) and previous
studies have shown that the composition of milk received
by the infant plays an important role in determining growth
trajectories (39).
In a recent study we reported on the association between
HM concentrations of adiponectin, leptin, IGF-1 and cGP
with maternal-infant characteristics in the STEPS cohort (40).
We identified significant differences in the concentrations
of HM-borne total protein, IGF-1, leptin and adiponectin
across mother-infant dyads, particularly in association
with maternal/perinatal/infant characteristics including
pre-pregnancy BMI, maternal education, birth mode,
gestational diabetes (GDM), and infant sex. Following our
initial observations, in the present study we hypothesized that
differences in HM composition would correlate with different
weight and BMI z-scores in the infants from birth to 5 years
of age.
MATERIALS AND METHODS
Study Design and Population
Characteristics
This study utilizes HM samples obtained from 501 mothers and
507 children participating in the Finnish longitudinal cohort,
Steps to healthy development of Children (the STEPS Study)
between 2008 and 2010, as described previously (40). HM
samples from consenting mothers were collected 2.6 ± 0.4
months after birth by manual expression in the morning, from
a single breast, as detailed previously (41). Study visit retention
decreased from birth (N = 507) to 5 years (N = 391) but
remained high at almost 80%. Maternal pre-pregnancy BMI was
calculated from self-reported height and weight and clustered
into the following categories: underweight < 18.5 kg/m2, normal
weight 18.5–24.9 kg/m2, overweight 25–29.9 kg/m2, obese
>29.9 kg/m2. Information regarding infant sex, birth weight
and length were obtained from the Longitudinal Census Files.
Information on feeding practices was collected through follow-
up diaries completed by mothers (42). Exclusive breastfeeding
was defined as the infant not receiving anything other than HM,
with the exception of water, supplements or medicines. Total
breastfeeding was defined as the infant receiving HM and any
other liquid or food. Infant anthropometric measures (weight,
length/height) were taken during follow-up visits at 13 months,
2, 3, and 5 years of age as previously detailed (42). These
measurements were used to calculate the BMI and respective z-
scores using references specific to the Finnish population (43).
Weight gain was calculated as difference between each clinical
visit and birth weight. The study protocol was approved by the
Ethics Committee of the Hospital District of Southwest Finland
in February 2007 andMarch 2015.Written informed consent was
obtained from all participants.
HM Analysis
HManalysis was undertaken in 2018 as described previously (40).
In brief, leptin, adiponectin and IGF-1 in HM were analyzed
using commercially available ELISA kits (human sensitive
leptin ELISA, human adiponectin ELISA, human IGF-1 ELISA,
Mediagnost, Germany), while cGP was analyzed via liquid
chromatography tandem mass spectrometry (LC-MS). HM total
protein was quantified by infrared spectrometry using the Direct
Detect R© technology (Merck, Germany) in order to normalize
hormone concentrations. The intra- and inter-assay coefficients
of variation, respectively, for the ELISAs (QCs supplied) were
adiponectin (5, 6%), IGF-1 (3, 9%), and leptin (4, 8%).
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TABLE 1 | Characteristics for the study population at each clinical visit.
Population characteristics Birth 13 months 2 years 3 years 5 years
Anthropometry, Mean (SD)
N (%) 507 (100) 504 (99) 448 (88) 405 (80) 391 (77)
Missing (%) 0 3 (1) 59 (12) 102 (20) 116 (23)
Weight (kg) 3.490 (0.506) 10.352 (1.108) 12.941 (1.351) 15.260 (1.613) 19.987 (2.521)
Weight (z-score) 0.18 (0.889) −0.19 (1.197) 0.08 (0.964) 0.09 (0.938) 0.22 (0.901)
BMI (kg/m2 ) NA NA 16.5 (1.2) 16.2 (1.1) 16.0 (1.3)
BMI (z-score) NA NA 0.04 (1.048) 0.21 (0.958) 0.08 (0.897)
Weight gain (kg) NA 6.86 (1.05) 9.44 (1.31) 11.76 (1.52) 16.49 (2.43)
Infant sex, N (%)
Male 273 (54) 270 (54) 245 (55) 219 (54) 212 (54)
Female 234 (46) 234 (46) 203 (45) 186 (46) 179 (46)
Maternal pre-pregnancy BMI, N (%)
Underweight 20 (4) 19 (4) 20 (4) 19 (5) 16 (4)
Normal weight 343 (68) 343 (68) 302 (67) 281 (69) 277 (71)
Overweight 91 (18) 91 (18) 85 (19) 70 (17) 63 (16)
Obese 51 (10) 51 (10) 41 (9) 35 (9) 35 (9)
Statistical Analyses
For the purpose of this study we only used weight and BMI
z-scores and weight gain as outcome variables, since these are
the primary predictors for childhood obesity (44). The power
provided by the smallest sample size (n = 391) amongst the
follow-up visits was above 90% for multiple linear regression
analyses at 5% significance level for the detection of small
effect sizes (G∗Power 3.1.9.2). Similar to our previous study,
HM concentrations of leptin adiponectin, IGF-1 and cGP were
corrected for total protein concentration in each sample (mg/ml)
and reported as ng/mg of protein per ml (ng/mg). Outcome
variables were assessed for normality with the Shapiro Wilk
test. Since the distribution of weight gain was not normal,
all weight gain variables were log10 transformed. Associations
between adipokine and growth factor concentrations in HM
and weight and BMI z-scores from 13 months to 5 years
were analyzed using multiple linear regression models (to assess
associations between HM composition and individual infant
outcomes at single time-points) and repeated measures mixed
models (to assess associations between HM composition and
individual infant outcomes across time-points from 13 months
to 5 years of age). Associations between hormone concentrations
in HM and weight gain from birth to each clinical visit (13
months, 2, 3, and 5 years) was also analyzed through multiple
linear regression models. Interactions of HM composition with
infant sex were examined in each model. Maternal BMI class
before pregnancy, birth weight, total duration of breastfeeding
as well as the time of introduction of solid foods were used
as correcting factors (45, 46) (fixed factors) in each regression
model (both multiple linear regression and repeated measures),
as they were significantly associated with infant growth outcomes
which was the dependent variable in our cohort (weight z-
scores, BMI z-scores and weight gain) during simple regression
analysis. Gestational age and birth-mode were also considered
as co-factors. However, since both variables strongly correlated
with birth weight, we only used the latter (47). No random
effects were evaluated in this study, but the use of repeated
measures mixed models was adopted in order to appropriately
deal with the missing data (e.g., any dropouts between clinical
visits). All statistical analyses were performed using IBM
SPSS (version 25).
RESULTS
Population Characteristics
Of the 507 infants whose mothers had consented for HM
hormone and growth factor analysis, 391 (77%) were followed up
until 5 years of age.
The overall characteristics of the study population are
reported in Table 1. Although the number of infants decreased
from one visit to the other, the proportion in infant sex, and
maternal pre-pregnancy BMI remained consistent throughout
the study. As shown by the mean z-scores for weight and
BMI, our study population did not differ from the general
Finnish population.
HM Adipokine and Growth Factor
Composition and Infant Growth
As shown in Table 2, higher concentrations of HM IGF-1 were
associated with higher weight at 13 months and lower weight
at 3 and 5 years, while higher milk-borne cGP was associated
with lower weight at 13 months and overall with lower weight
z-scores across the 5 years, as indicated by the results of the
repeated measures regression (Table 2). Higher IGF-1 was also
associated with lower weight gain from birth to 2 years (Table 3)
and higher cGP was associated with higher BMI at 5 years of
age. No significant associations were found between HM leptin
and adiponectin and infant growth and there were no sex-specific
interactions (data not shown).
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DISCUSSION
The present study shows that HM bioactive concentrations
3 months after birth were significantly associated with infant
growth, even when adjusted for important confounding factors
including birth weight, maternal pre-pregnancy BMI, total
duration of breastfeeding and timing of introduction of solid
foods. Our results suggest that milk-borne IGF-1 and cGP are
related to weight and z-scores up to 5 years of age and weight
gain up to 2 years of age.
While IGF-1 is the main growth factor during infancy (48),
results on the relationship between different concentrations of
IGF-1 inHMand infant growth outcomes are conflicting (49, 50).
In the current cohort, concentrations of IGF-1 in HM collected 3
months after birth were associated with higher weight z-scores at
13 months and associated with lower weight z-scores at 3 and 5
years of age. Previous work by Ong et al. reported that circulating
concentrations of IGF-1 at 5 years of age were inversely correlated
to birth weight and positively correlated to current weight
and weight gain from birth to 2 years of age, concluding that
circulating IGF-1 in childhood is linked to growth rates in
infancy (51). In the present study we found that HM IGF-
1 concentrations were significantly associated with the same
outcomes (i.e., weight, weight gain) but in the opposite direction
compared to serum IGF-1. This suggests that HM IGF-1 could be
involved in production pathways for endogenous IGF-1.
In this context, previous studies in both experimental animal
models and clinical settings have reported that circulating IGF-
1 during infancy is strongly regulated by nutrition (52, 53). In
particular, breastfed infants have lower circulating IGF-1 and
lower weight gain compared to formula fed infants (53). The only
study to our knowledge that has examined IGF-1 concentrations
in infant formula reported undetectable amounts of bovine IGF-
1 [identical to human IGF-1 (54)] in the milk used in the formula
production (55). While we do not know if bovine IGF-1 would
be active in human infants or not (56), the presence of IGF-
1 in HM as opposed to its absence/inactivity in infant formula
might contribute to differences in endogenous IGF-1 regulation
between breastfed and formula-fed infants.
While the impact of dietary IGF-1 on endogenous IGF-1
synthesis is not known, a previous study in a murine
IGF-1R knock out model suggested an effect of IGF-1
signaling in adipocytes on systemic concentrations of IGF-1
(57). Such effects on systemic concentrations of IGF-1 was
independent of alterations in growth hormone (GH) secretion
and resulted in changes in somatic growth. Interestingly,
decreased IGF-1 signaling resulted in higher weight gain and
adipocyte hypertrophy. The study also found that increased
IGF-1 signaling exerted a negative feedback on circulating
IGF-1 (57). In light of this, we speculate that dietary and HM
IGF-1 during early life might play a role in adipose tissue
IGF-1 signaling, so that higher HM concentrations of IGF-1
may downregulate circulating IGF-1 and reduce infant weight
gain and weight z-scores in the long term. Although in the
present study we did not have the means to examine circulating
concentrations of IGF-1 in the infants, it is possible that HM
IGF-1may explain why breastfed infants display lower circulating
Frontiers in Nutrition | www.frontiersin.org 4 July 2020 | Volume 7 | Article 110
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TABLE 3 | Associations between weight gain and BMI z-scores and HM composition.
1Weight from birth [log10(Kg)]
Weight gain from birth to 13 months Weight gain from birth to 2 years Weight gain from birth to 3 years Weight gain from birth to 5 years
HM composition B (95% CI) p B (95% CI) p B (95% CI) p B (95% CI) p
Leptin (ng/mg) −0.008 (−0.142, 0.125) 0.905 0 (−0.146, 0.145) 0.995 0.012 (−0.131, 0.155) 0.872 0.073 (−0.087, 0.232) 0.371
Adiponectin (ng/mg) 0.016 (−0.011, 0.043) 0.256 0.018 (−0.009, 0.045) 0.193 0.014 (−0.012, 0.040) 0.281 0.002 (−0.027, 0.031) 0.882
IGF-1 (ng/mg) −0.023 (−0.068, 0.021) 0.305 –0.060 (–0.107, –0.014) 0.011 −0.047 (−0.094, 0) 0.051 −0.050 (−0.106, 0.006) 0.083
cGP (ng/mg) −0.022 (−0.055, 0.010) 0.177 0.005 (−0.021, 0.030) 0.73 0.019 (−0.012, 0.050) 0.228 0.009 (−0.028, 0.047) 0.627
IGF-1:cGP ratio 0.002 (−0.009, 0.013) 0.667 −0.007 (−0.014, 0.001) 0.075 −0.006 (−0.015, 0.002) 0.148 −0.009 (−0.019, 0.002) 0.102
Protein (mg/ml) −0.001 (−0.004, 0.002) 0.428 −0.001 (−0.004, 0.002) 0.435 −0.001 (−0.004, 0.001) 0.243 −0.003 (−0.006, 0) 0.086
BMI z-scores
BMI 2 years BMI 3 years BMI 5 years BMI across time
HM composition B (95% CI) p B (95% CI) p B (95% CI) p B (95% CI) p
Leptin (ng/mg) 0.522 (−1.898, 2.942) 0.672 −0.643 (−2.675, 1.390) 0.535 0.067 (−2.0.40, 2.175) 0.95 0.059 (−1.477, 1.596) 0.939
Adiponectin (ng/mg) 0.039 (−0.435, 0.513) 0.871 0.348 (−0.053, 0.749) 0.089 0.089 (−0.315, 0.492) 0.666 0.104 (−0.235, 0.442) 0.548
IGF-1 (ng/mg) −0.818 (−1.755, 0.119) 0.087 −0.542 (−1.336, 0.252) 0.181 −0.480 (−1.270, 0.309) 0.233 −0.615 (−1.301, 0.070) 0.078
cGP (ng/mg) −0.213 (−0.813, 0.387) 0.486 0.276 (−0.144, 0.696) 0.197 0.507 (0.076, 0.938) 0.021 0.149 (−0.202, 0.500) 0.405
IGF-1:cGP ratio 0.020 (−0.191, 0.232) 0.851 –0.212 (–0.312, –0.113) p < 0.001 –0.235 (–0.350, –0.120) p < 0.001 −0.130 (−0.300, 0.040) 0.133
Protein (mg/ml) −0.015 (−0.067, 0.038) 0.583 −0.010 (−0.056, 0.035) 0.656 −0.017 (−0.061, 0.026) 0.435 −0.013 (−0.047, 0.020) 0.436
Values represent parameter estimates obtained by each individual fitted regression model with the following cofactors: maternal pre-pregnancy BMI, birthweight, infant sex, total breastfeeding duration and introduction of solid foods.
IGF-1, Insulin-like growth factor-1; cGP, cyclic Glycine Proline; B, unstandardized beta coefficients. BMI and weight z-scores were calculated using reference values specific to the Finnish population (43). Weight gain was calculated as
difference between each clinical visit and birth weight. Bold values indicate significant p-values.
F
ro
n
tie
rs
in
N
u
tritio
n
|w
w
w
.fro
n
tie
rsin
.o
rg
5
Ju
ly
2
0
2
0
|V
o
lu
m
e
7
|
A
rtic
le
1
1
0
Galante et al. Breastmilk IGF-1 and Infant Growth
IGF-1 concentrations as compared to formula-fed infants.
Considering that weight gain during infancy is a predictor of
adiposity later in life (38) further studies investigating the role
of HM IGF-1 as a mediator of weight gain during infancy
are required.
While we did not measure IGF-1 binding proteins in our
cohort, we analyzed cGP, a metabolite of IGF-1. cGP has been
reported to play a regulatory function in relation to IGF-1
activity by maintaining IGF-1 homeostasis through competing
against IGFBP-3 binding sites on IGF-1 (58). In our study, the
analysis of the associations between weight and BMI z-scores
and cGP concentrations in HM highlights a reversed action of
cGP compared to that observed for IGF-1. This, together with
the fact that both cGP and IGF-1 concentrations in HM were
significantly associated with infant growth, further suggests that
cGPmay be modulating IGF-1 bioactivity in humans, as reported
previously, with the ratio between the two indicating IGF-1
bioactivity (58). In this context, a higher ratio between IGF-1 and
cGP (IGF-1/cGP), was associated with BMI at 3 and 5 years of
age. Lastly, higher HM cGP concentrations were associated with
lower weight z-scores trajectories over time suggesting that cGP
may exert regulatory effects on IGF-1 activity in both directions
(i.e., cGP may enhance the activity of IGF-1 when at low
concentrations and reducing activity when IGF-1 is in excess).
Neither leptin nor adiponectin displayed significant
associations with infant growth outcomes in the long term,
despite some studies suggesting that these compounds may
also have a role in infant development and growth (28, 59, 60).
Overall, the existing literature in this context is conflicting [see
(37) for review] and disparities in the findings are, in part, likely
due to different approaches as regards sample collection and
storage, laboratory approaches used and statistical analysis of the
data, as infant growth is influenced by a complex array of factors.
While some of these, including basic characteristics, that can be
identified and controlled for, other factors, including potential
synergism/antagonism between our hormones of interest and
other bioactive factors in HM (37), are difficult to control for.
The lack of associations in the present cohort between HM
adipokine concentrations and infant BMI and weight does
not preclude associations with infant body composition per se,
as leptin in particular has been linked to eating behavior and
fat mass (11).
The main strength of the present study was the large sample
size and the prolonged follow-up data that allowed us to
investigate associations between HM composition around 3
months postpartum and infant growth trajectories up to 5 years
of age. Unfortunately, due to the lack of infant blood samples,
we could not investigate the relationship between maternal
HM bioactive concentrations and the respective circulating
concentrations in the infant. Furthermore, while we were able
to detect the concentrations in the samples given, the actual
amount of bioactive IGF-1 received by the infant (i.e., not
bound to binding proteins that limit its bioavailability) remains
unknown. Certainly, the collection of maternal and infant blood
samples as well as that of HM at more than one time-point
would have aided in the formulation of hypothesis around
possible mechanisms underlying our observations. While only
one HM sample per mother was available, this was representative
of mature milk, which is fairly stable across lactation (61),
thus ideally representative of the entire lactation period from
the first month to weaning. Of note, despite HM collection
occurring on average 3 months after birth, we did not find any
association between hormone concentration and exact time of
collection, indicating that hormone concentrations were stable
across slightly different collection times. The interpretation of
the current findings are also limited by a number of factors (e.g.,
infant diet and physical activity) that were not available to us and
that will impact on growth trajectories up to 5 years. Evaluating
the eating behavior and body composition of the infant would
also been valuable in relation to HM leptin.
Overall, although the variation in BMI and weight z-scores in
the present population was generally small with values proximal
to zero, IGF-1, and cGP displayed significant associations
with infant growth outcomes. This, together with evidence
arising from other studies in the same cohort (62), suggests
a role for HM-borne compounds in contributing to postnatal
growth trajectories. As the role of IGF-1 in association with
adiposity in infancy remains poorly understood and current data
remain conflicting, more comprehensive studies are required to
investigate the mechanistic role of IGF-1 and cGP in HM and
early development.
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